Evaluation of the Effect of Repeated Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using Optical Coherence Tomography Angiography
Phase of Trial: Phase IV
Latest Information Update: 03 Jan 2019
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 24 Dec 2018 Status changed from recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 25 May 2018 Planned End Date changed from 1 Jun 2018 to 1 Feb 2019.